Askeyev Baglan, Adachi Tomohiko, Imamura Hajime, Yamashita Mampei, Nagakawa Kantoku, Hara Takanobu, Matsushima Hajime, Soyama Akihiko, Baimakhanov Zhassulan, Baimakhanov Bolatbek, Eguchi Susumu
Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Department of HPB Surgery and Liver Transplantation, Syzganov's National Scientific Center of Surgery, Almaty, Kazakhstan.
Am J Case Rep. 2024 Aug 8;25:e944405. doi: 10.12659/AJCR.944405.
BACKGROUND Minimally invasive pancreatectomy has become the standard practice for the management of benign and malignant pancreatic tumors. Techniques such as robotic and laparoscopic approaches are known to reduce morbidity by offering benefits such as less blood loss, reduced pain, shorter hospital stays, and quicker recovery times. The indication for repeated minimally invasive pancreatectomy for recurrent or de novo pancreatic neoplasm after primary pancreatic surgery remains debated. CASE REPORT A 50-year-old woman was admitted to our hospital with a diagnosis of an intraductal papillary mucinous neoplasm in the pancreatic head. In 2010, she underwent laparoscopic single-branch resection for a branch-type tumor in the pancreatic uncinate process. During a 5-year follow-up, a de novo intraductal papillary mucinous neoplasm was detected, showing gradual growth and the presence of a mural nodule over the next 7 years. The patient's CEA level was elevated to 7.0 ng/mL. Considering the tumor's progression and the appearance of a mural nodule, we recommended a robot-assisted Whipple procedure. The operation began with laparoscopic adhesiolysis. After detachment of the adhesions and remobilization of the duodenum using the Kocher maneuver, the operation continued with the Da Vinci surgical system. The postoperative period was uneventful, and the patient was discharged on postoperative day 20. Pathological examination revealed intraductal papillary mucinous carcinoma in situ with negative resection margins. CONCLUSIONS This case verifies the safety and feasibility of performing a robotic Whipple procedure for a newly diagnosed pancreatic neoplasm in patients who have previously undergone minimally invasive pancreatic surgery.
背景 微创胰腺切除术已成为治疗胰腺良恶性肿瘤的标准术式。诸如机器人手术和腹腔镜手术等技术,因其具有减少失血、减轻疼痛、缩短住院时间及加快恢复速度等优点,而被认为可降低发病率。对于初次胰腺手术后复发或新发胰腺肿瘤再次行微创胰腺切除术的适应证仍存在争议。
病例报告 一名50岁女性因胰头导管内乳头状黏液性肿瘤入院。2010年,她因胰腺钩突部的分支型肿瘤接受了腹腔镜单分支切除术。在5年的随访中,发现了新发的导管内乳头状黏液性肿瘤,在接下来的7年中肿瘤逐渐生长并出现壁结节。患者的癌胚抗原(CEA)水平升高至7.0 ng/mL。考虑到肿瘤进展及壁结节的出现,我们建议行机器人辅助胰十二指肠切除术。手术首先进行腹腔镜粘连松解术。使用Kocher手法分离粘连并游离十二指肠后,继续使用达芬奇手术系统进行手术。术后过程顺利,患者于术后第20天出院。病理检查显示原位导管内乳头状黏液癌,切缘阴性。
结论 该病例证实了对于既往接受过微创胰腺手术的患者,为新诊断的胰腺肿瘤行机器人胰十二指肠切除术的安全性和可行性。